Monday, June 24, 2013

Of the 86 drugs in the industry's diabetes pipeline, how many agents are truly innovative and how many are simply me-toos?

http://www.fiercebiotech.com/story/innovation-not-imitation-
needed-diabetes-drug-development/2013-06-23?utm_source=rss&utm_medium=rss

No comments: